10.11.2021 To the attention of interested persons EMA starts evaluating use of COVID-19 vaccine Spikevax in children aged 6 to […]

08.11.2021 To the attention of interested persons COVID-19: EMA and Heads of Medicines Agencies update on molnupiravir; EMA starts review […]

02.11.2021 To the attention of interested persons EMA ends rolling review of the antibodies bamlanivimab and etesevimab for COVID-19 following […]

02.11.2021 To the attention of interested persons Questions and answers on end of rolling review for antibodies bamlanivimab and etesevimab […]

29.10.2021 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021 download […]

25.10.2021 To the attention of interested persons Spikevax: EMA recommendation on booster download document …

25.10.2021 To the attention of interested persons COVID-19: EMA starts rolling review of molnupiravir download document …

12.10.2021 To the attention of interested persons Questions and answers on end of rolling review for CureVac’s COVID-19 vaccine (CVnCoV) […]

14.10.2021 To the attention of interested persons EMA starts rolling review of Evusheld (tixagevimab and cilgavimab) download document …

12.10.2021 To the attention of interested persons EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG […]